Profound Medical Corp.
PROF
$4.71
$0.183.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 820.00K | 1.06M | 179.00K | 773.00K | 428.00K |
| Total Other Revenue | 1.80M | 2.65M | 2.65M | 1.46M | 1.44M |
| Total Revenue | 2.62M | 3.71M | 2.83M | 2.23M | 1.44M |
| Cost of Revenue | 768.00K | 1.18M | 1.03M | 795.00K | 573.00K |
| Gross Profit | 1.85M | 2.52M | 1.81M | 1.44M | 866.00K |
| SG&A Expenses | 8.21M | 6.60M | 6.64M | 5.08M | 4.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.79M | 12.46M | 11.82M | 10.07M | 9.32M |
| Operating Income | -11.17M | -8.76M | -8.99M | -7.83M | -7.88M |
| Income Before Tax | -10.68M | -5.57M | -9.19M | -6.90M | -6.55M |
| Income Tax Expenses | 41.00K | -238.00K | 177.00K | 20.00K | 40.00K |
| Earnings from Continuing Operations | -10.72M | -5.33M | -9.36M | -6.92M | -6.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.72M | -5.33M | -9.36M | -6.92M | -6.59M |
| EBIT | -11.17M | -8.76M | -8.99M | -7.83M | -7.88M |
| EBITDA | -11.00M | -8.39M | -8.82M | -7.64M | -7.63M |
| EPS Basic | -0.36 | -0.21 | -0.38 | -0.28 | -0.27 |
| Normalized Basic EPS | -0.22 | -0.14 | -0.23 | -0.18 | -0.17 |
| EPS Diluted | -0.36 | -0.21 | -0.38 | -0.28 | -0.27 |
| Normalized Diluted EPS | -0.22 | -0.14 | -0.23 | -0.18 | -0.17 |
| Average Basic Shares Outstanding | 30.04M | 25.77M | 24.54M | 24.44M | 24.30M |
| Average Diluted Shares Outstanding | 30.04M | 25.77M | 24.54M | 24.44M | 24.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |